+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dermatological Drugs Market Research Reports

From
US Vitiligo Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Vitiligo Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
US Acne Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Acne Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
From
US Urticaria Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Urticaria Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
US Rosacea Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Rosacea Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
From
From
From
From
From
From
Global Eczema Epidemiology and Patient Flow - 2021 - Product Thumbnail Image

Global Eczema Epidemiology and Patient Flow - 2021

  • Report
  • February 2021
  • Global
From
From
From
Global Acne Epidemiology and Patient Flow - 2021 - Product Thumbnail Image

Global Acne Epidemiology and Patient Flow - 2021

  • Report
  • February 2021
  • Global
From
Loading Indicator

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally. The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more